Drug-induced resistance evolution necessitates less aggressive treatment.
Increasing body of experimental evidence suggests that anticancer and antimicrobial therapies may themselves promote the acquisition of drug resistance by increasing mutability. The successful control of evolving populations requires that such biological costs of control are identified, quantified a...
Guardado en:
Autores principales: | Teemu Kuosmanen, Johannes Cairns, Robert Noble, Niko Beerenwinkel, Tommi Mononen, Ville Mustonen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba08f29bd91c4066a56d33bb658e0f4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Jacques Derrida, la sémiologie, le structuralisme : entre nécessité et contingence historique
por: Maxime Plante
Publicado: (2018) -
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
por: Bi-Dar Wang, et al.
Publicado: (2017) -
Spatial disease dynamics of free-living pathogens under pathogen predation
por: Tommi Mononen, et al.
Publicado: (2017) -
Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data
por: Salem Malikic, et al.
Publicado: (2019) -
Flora Tristan: <i>De la nécessité de faire bon accueil aux femmes étrangères</i>
por: Martine Reid
Publicado: (2014)